T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Costamare
CMRE
$1.74B
| $222K | ﹤0.01% |
14,085
+463
| +3% | +$6.67K |
|
2602
Editas Medicine
EDIT
$438M
| $222K | ﹤0.01% |
64,818
+12,363
| +24% | +$53.8K |
|
2603
UWM Holdings
UWMC
$2.65B
| $222K | ﹤0.01% |
25,953
+3,132
| +14% | +$26.4K |
|
2604
Miller Industries
MLR
$634M
| $221K | ﹤0.01% |
+3,615
| New | +$217K |
|
2605
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.5B
| $221K | ﹤0.01% |
2,200
| – | – |
|
2606
Canterbury Park Holding Corp
CPHC
$80.1M
| $220K | ﹤0.01% |
11,379
| – | – |
|
2607
DXP Enterprises
DXPE
$3B
| $220K | ﹤0.01% |
+4,115
| New | +$207K |
|
2608
Horizon Bancorp
HBNC
$1.05B
| $220K | ﹤0.01% |
14,085
+372
| +3% | +$5.54K |
|
2609
Seaboard Corp
SEB
$4.02B
| $220K | ﹤0.01% |
+70
| New | +$218K |
|
2610
ArriVent BioPharma
AVBP
$1.41B
| $220K | ﹤0.01% |
+9,345
| New | +$212K |
|
2611
Cytek Biosciences
CTKB
$634M
| $219K | ﹤0.01% |
39,503
+1,176
| +3% | +$6.67K |
|
2612
SPDR Gold Trust
GLD
$142B
| $219K | ﹤0.01% |
+900
| New | +$206K |
|
2613
Veritone
VERI
$139M
| $218K | ﹤0.01% |
60,500
| – | – |
|
2614
Asure Software
ASUR
$250M
| $217K | ﹤0.01% |
23,960
+348
| +1% | +$3.1K |
|
|
BBUC
2615
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$6.02B
| $217K | ﹤0.01% |
+8,533
| New | +$188K |
|
2616
Orrstown Financial Services
ORRF
$850M
| $217K | ﹤0.01% |
+6,015
| New | +$199K |
|
2617
indie Semiconductor
INDI
$879M
| $216K | ﹤0.01% |
53,904
+1,715
| +3% | +$8.33K |
|
2618
Kelly Services Class A
KELYA
$558M
| $216K | ﹤0.01% |
10,085
+319
| +3% | +$6.76K |
|
2619
Klaviyo
KVYO
$5.5B
| $216K | ﹤0.01% |
+6,079
| New | +$176K |
|
2620
Dianthus Therapeutics
DNTH
$6.19B
| $215K | ﹤0.01% |
+7,821
| New | +$218K |
|
2621
SIGA Technologies
SIGA
$208M
| $215K | ﹤0.01% |
31,715
+1,278
| +4% | +$11.2K |
|
2622
Avita Medical
RCEL
$249M
| $213K | ﹤0.01% |
19,800
-255
| -1% | -$2.4K |
|
2623
Atlanticus Holdings
ATLC
$1.48B
| $211K | ﹤0.01% |
+6,011
| New | +$199K |
|
|
GDEN
2624
DELISTED
Golden Entertainment
GDEN
| $210K | ﹤0.01% |
6,593
+185
| +3% | +$5.71K |
|
2625
Blink Charging
BLNK
$87.1M
| $207K | ﹤0.01% |
120,022
+26,700
| +29% | +$63.7K |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.